Overview

Immunara develops AI-powered tools for immunology research. It builds large-scale biological foundation models trained on multimodal human data to model diseases and predict how patients will respond to interventions. It also creates AI agents trained with reinforcement learning that reason over biological data, generate hypotheses, and design experiments. Together, these tools help researchers understand immune diseases faster and identify effective treatments. Compared with other players, Immunara focuses specifically on immunology with integrated, multimodal models plus action-oriented AI agents that can propose experiments, aiming to accelerate discovery. The company’s goal is to speed up the development of treatments for immune-mediated diseases by turning complex biological data into actionable experiments and patient-response predictions.